GSK343,
GSK343,
1346704-33-3,
GSK 343,
GSK-343,
1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide,
CHEMBL2204995,
C31H39N7O2,
1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide,
N-[(6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-(propan-2-yl)-1H-indazole-4-carboxamide,
compound 6 [PMID 24900432],
GTPL8240,
SCHEMBL14716863,
AOB3680,
EX-A244,
SYN5151,
BCP07777,
2449AH,
BDBM50400778,
MFCD25563250,
ZINC95564006,
AKOS025405231,
CS-1626,
NCGC00351480-11,
AK175558,
AS-16513,
BC600349,
GSK343, >=98% (HPLC),
HY-13500,
QC-11809,
AB0199866,
FT-0767292,
S7164,
J3.544.025I,
J-006589,
N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide,
N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-propan-2-ylindazole-4-carboxamide,
D02TVQ,
ACN-053701,
A3449,
A13114,
C586265,